ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 80 announcements

Alembic Pharmaceuticals Ltd news stories on ALFA NewsRead the news →
Share price
₹1,029.95
Market cap
₹20,245 Cr
Revenue (annual)
₹7,345 Cr
Net profit (annual)
₹674.8 Cr
P/E (TTM)
24.0×Sector 43.8×
Promoter holding
69.87%+0.00% QoQ
FII holding
4.55%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:26 IST BSE
Financial Results

Alembic Pharmaceuticals Q2 FY27 Results: Net Profit ₹335.2 Cr, Up 81.5% YoY

Alembic Pharmaceuticals Ltd reported revenue from operations of ₹2,604 Cr (+36.3% YoY) and net profit of ₹335.2 Cr (+81.5% YoY) for Q2 FY27.

Key figure
Net profit ₹335.2 Cr · +81.5% YoY
14:50 IST NSE
Financial Results

Alembic Pharmaceuticals Q4 FY26 Results: Net Profit ₹202.7 Cr, Up 29.2% YoY

Alembic Pharmaceuticals Ltd reported revenue from operations of ₹1,848 Cr (+4.4% YoY) and net profit of ₹202.7 Cr (+29.2% YoY) for Q4 FY26.

Key figure
Net profit ₹202.7 Cr · +29.2% YoY
14:46 IST BSE
Financial Results

Alembic Pharmaceuticals Q4 FY26 Results: Net Profit ₹201.5 Cr, Up 28.7% YoY

Alembic Pharmaceuticals Ltd reported revenue from operations of ₹1,848 Cr (+4.4% YoY) and net profit of ₹201.5 Cr (+28.7% YoY) for Q4 FY26.

Key figure
Net profit ₹201.5 Cr · +28.7% YoY